Catalent plans for the opening of new facility. This expansion will further increase the clinical supply network.
The new construction will support the growing demand for pharmaceutical and biopharmaceutical customers for integrated development, clinical packaging, and distribution solutions.
The new facility covers an area of 24,000-square-foot build within the early-phase oral drug product center of excellence, which is dedicated to support clinical studies in phases 1-3. In addition, the facility enables to offer end-to-end services consisting supply management, primary and secondary packaging and labeling, storage, distribution, returns and destruction.
The clinical supply services handles a broad range of international compliance and distribution requirements to support global clinical trials across U.S., U.K., Germany, Singapore, Japan and China.
The new full-service facility of development center will better serve customers not only on the West Coast of the U.S. and Canada but allover the world.